These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Recombinant tissue plasminogen activator in patients with pulmonary embolism: correlation of fibrinolytic specificity and efficacy. Vaughan DE; Goldhaber SZ; Kim J; Loscalzo J Circulation; 1987 Jun; 75(6):1200-3. PubMed ID: 3105914 [TBL] [Abstract][Full Text] [Related]
3. Early reversal of right ventricular dysfunction in patients with acute pulmonary embolism after treatment with intravenous tissue plasminogen activator. Come PC; Kim D; Parker JA; Goldhaber SZ; Braunwald E; Markis JE J Am Coll Cardiol; 1987 Nov; 10(5):971-8. PubMed ID: 2959713 [TBL] [Abstract][Full Text] [Related]
4. Reduced dose bolus alteplase vs conventional alteplase infusion for pulmonary embolism thrombolysis. An international multicenter randomized trial. The Bolus Alteplase Pulmonary Embolism Group. Goldhaber SZ; Agnelli G; Levine MN Chest; 1994 Sep; 106(3):718-24. PubMed ID: 8082347 [TBL] [Abstract][Full Text] [Related]
5. Tissue-plasminogen activator for pulmonary embolism resulting in shock: two case reports and discussion of the literature. Mitchell JP; Trulock EP Am J Med; 1991 Feb; 90(2):255-60. PubMed ID: 1899967 [TBL] [Abstract][Full Text] [Related]